Microbot Medical Files 8-K
Ticker: MBOT · Form: 8-K · Filed: Sep 11, 2024 · CIK: 883975
| Field | Detail |
|---|---|
| Company | Microbot Medical Inc. (MBOT) |
| Form Type | 8-K |
| Filed Date | Sep 11, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k
TL;DR
Microbot Medical filed a standard 8-K, no major news.
AI Summary
Microbot Medical Inc. filed an 8-K on September 11, 2024, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or material events beyond the standard reporting requirements.
Why It Matters
This filing indicates routine corporate reporting by Microbot Medical Inc. to the SEC, without disclosing new material information.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report and does not contain any new material information that would indicate increased risk.
Key Players & Entities
- Microbot Medical Inc. (company) — Registrant
- September 11, 2024 (date) — Date of earliest event reported
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to provide Financial Statements and Exhibits.
What is the exact name of the registrant?
The exact name of the registrant is Microbot Medical Inc.
In which state was Microbot Medical Inc. incorporated?
Microbot Medical Inc. was incorporated in Delaware.
What is the Commission File Number for Microbot Medical Inc.?
The Commission File Number for Microbot Medical Inc. is 000-19871.
What is the address of the Principal Executive Offices?
The address of the Principal Executive Offices is 288 Grove Street, Suite 388, Braintree, MA 02184.
Filing Stats: 524 words · 2 min read · ~2 pages · Grade level 11 · Accepted 2024-09-11 13:00:40
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value MBOT NASDAQ Capital Mark
Filing Documents
- form8-k.htm (8-K) — 39KB
- ex99-1.htm (EX-99.1) — 21KB
- ex99-1_001.jpg (GRAPHIC) — 200KB
- ex99-1_002.jpg (GRAPHIC) — 597KB
- ex99-1_003.jpg (GRAPHIC) — 179KB
- ex99-1_004.jpg (GRAPHIC) — 422KB
- ex99-1_005.jpg (GRAPHIC) — 338KB
- ex99-1_006.jpg (GRAPHIC) — 221KB
- ex99-1_007.jpg (GRAPHIC) — 266KB
- ex99-1_008.jpg (GRAPHIC) — 316KB
- ex99-1_009.jpg (GRAPHIC) — 242KB
- ex99-1_010.jpg (GRAPHIC) — 249KB
- ex99-1_011.jpg (GRAPHIC) — 245KB
- ex99-1_012.jpg (GRAPHIC) — 223KB
- ex99-1_013.jpg (GRAPHIC) — 257KB
- ex99-1_014.jpg (GRAPHIC) — 266KB
- ex99-1_015.jpg (GRAPHIC) — 195KB
- ex99-1_016.jpg (GRAPHIC) — 14KB
- ex99-1_017.jpg (GRAPHIC) — 220KB
- ex99-1_018.jpg (GRAPHIC) — 291KB
- ex99-1_019.jpg (GRAPHIC) — 14KB
- ex99-1_020.jpg (GRAPHIC) — 259KB
- ex99-1_021.jpg (GRAPHIC) — 190KB
- ex99-1_022.jpg (GRAPHIC) — 289KB
- ex99-1_023.jpg (GRAPHIC) — 308KB
- ex99-1_024.jpg (GRAPHIC) — 261KB
- ex99-1_025.jpg (GRAPHIC) — 200KB
- 0001493152-24-035757.txt ( ) — 8858KB
- mbot-20240911.xsd (EX-101.SCH) — 3KB
- mbot-20240911_lab.xml (EX-101.LAB) — 33KB
- mbot-20240911_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. MICROBOT MEDICAL INC. By: /s/ Harel Gadot Name: Harel Gadot Title: Chief Executive Officer, President and Chairman Date: September 11, 2024